Genic Co., Ltd. Stock

Equities

A123330

KR7123330003

Personal Products

End-of-day quote Korea S.E. 06:00:00 2024-05-23 pm EDT 5-day change 1st Jan Change
3,350 KRW -0.89% Intraday chart for Genic Co., Ltd. -2.62% -6.94%
Sales 2022 31.45B 23.02M Sales 2023 28.07B 20.55M Capitalization 24.68B 18.07M
Net income 2022 -3.34B -2.44M Net income 2023 -4.41B -3.23M EV / Sales 2022 1.12 x
Net Debt 2022 5.15B 3.77M Net Debt 2023 5.38B 3.94M EV / Sales 2023 1.07 x
P/E ratio 2022
-9.03 x
P/E ratio 2023
-5.6 x
Employees 204
Yield 2022 *
-
Yield 2023
-
Free-Float 67.27%
More Fundamentals * Assessed data
Dynamic Chart
Genic Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Genic Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Genic Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Genic Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Genic Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Genic Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Genic Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Genic Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Genic Shanghai Cosmetics announced that it has received KRW 10.3105 billion in funding from Genic Co., Ltd. CI
Genic Shanghai Cosmetics announced that it expects to receive KRW 10.3105 billion in funding from Genic Co., Ltd. CI
Genic Co., Ltd.(KOSDAQ:A123330) dropped from S&P Global BMI Index CI
Genic Co., Ltd. announced that it has received KRW 5 billion in funding from Soulbrain Co.,Ltd. CI
Genic Shanghai Cosmetics announced that it expects to receive KRW 2.93 billion in funding from Genic Co., Ltd. CI
Soulbrain Co.,Ltd. completed the acquisition of 24.78% stake in Genic Co., Ltd. from Hyun-ho Yoo. CI
Soulbrain Co.,Ltd. signed a contract to acquire 24.78% stake in Genic Co., Ltd. from Hyun-ho Yoo and 4 other individuals for KRW 70 billion. CI
More news
1 day-0.89%
1 week-2.62%
Current month-3.60%
1 month+3.24%
3 months-7.71%
6 months-6.94%
Current year-6.94%
More quotes
1 week
3 325.00
Extreme 3325
3 775.00
1 month
3 280.00
Extreme 3280
3 775.00
Current year
3 175.00
Extreme 3175
4 095.00
1 year
3 150.00
Extreme 3150
4 920.00
3 years
3 150.00
Extreme 3150
9 970.00
5 years
1 890.00
Extreme 1890
9 970.00
10 years
1 890.00
Extreme 1890
43 283.65
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 -
Chief Executive Officer 54 -
Director/Board Member 57 17-03-23
Members of the board TitleAgeSince
Director/Board Member 57 17-03-23
Director/Board Member 57 18-06-20
Director/Board Member 58 20-03-30
More insiders
Date Price Change Volume
24-05-24 3,350 -0.89% 168,289
24-05-23 3,380 -0.29% 18,411
24-05-22 3,390 +0.30% 19,511
24-05-21 3,380 -0.15% 22,708
24-05-20 3,385 -1.60% 5,295

End-of-day quote Korea S.E., May 23, 2024

More quotes
GENIC Co., Ltd is a Korea-based company engaged in the manufacture of cosmetic products. The Company’s products consist of gel masks, essence masks, gel eye patches, self-heating masks, cleaners, basics and other skin care products, makeup products, hair care products, perfumes, as well as men cosmetics, body care products and manicures. The Company markets its products under the brand names of Cel-Derma, Lasante, Puretree and others. The Company distributes its products within domestic market and to overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. A123330 Stock